Shopping Cart
- Remove All
Your shopping cart is currently empty
TSHR antagonist S37
Catalog No. T13216Cas No. 1217616-61-9
TSHR antagonist S37 is a selective and competitive antagonist of the thyrotropin receptor (TSHR).
TSHR antagonist S37
Catalog No. T13216Cas No. 1217616-61-9
TSHR antagonist S37 is a selective and competitive antagonist of the thyrotropin receptor (TSHR).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $62 | In Stock | |
| 2 mg | $88 | In Stock | |
| 5 mg | $139 | In Stock | |
| 10 mg | $223 | In Stock | |
| 25 mg | $413 | In Stock | |
| 50 mg | $615 | In Stock | |
| 100 mg | $876 | In Stock | |
| 500 mg | $1,780 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $185 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "TSHR antagonist S37"
NCGC00229600
T121921338824-20-6
NCGC00229600 is an allosteric inverse thyrotropin receptor (TSHR) agonist. NCGC00229600 inhibits both TSH and stimulating antibody activation of TSHRs endogenously and can be used in Graves' disease studies.
- $58
Size
QTY
VA-K-14 hydrochloride
VAK14 Hydrochloride, VA-K-14 HCl, VAK14 HCl, VA K 14 HCl
T290871171341-19-7In house
VA-K-14 hydrochloride（VAK14 HCl） is a selective thyrotropin receptor (TSHR) antagonist (IC50= 12.3 μM) that inhibits TSHR stimulation by serum and monoclonal TSHR-stimulating antibodies from patients with GD and abrogates TSHR signaling.
- $54
Size
QTY
D3-βArr
NCGC00379308
T5383662164-09-2
D3-βArr (NCGC00379308) is a positive allosteric modulator for thyrotropin receptor (TSHR), which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.
- $40
Size
QTY
ML-109
Cited
T120731186649-91-1
ML-109 is a potent agonist of thyroid stimulating hormone receptor (TSHR) (EC50 of 40 nM)
- $31
Size
QTY
CitedML224
NCGC00242364, ANTAG3
T161061338824-21-7
ML224 (NCGC00242364) is a TSHR antagonist for the treatment of Graves' orbital disease and Graves' hyperthyroidism.
- $52
Size
QTY
Org41841
Org-41841
T16403301847-37-0
Org41841 is an agonist of luteinising hormone/chorionic gonadotropin receptor and thyroid stimulating hormone receptor (EC50s: 0.2 and 7.7 μM, respectively) and can be used to study hyperthyroidism.
- $199
Size
QTY
Teprotumumab
R 1507, HZN 001
T767271036734-93-6
Teprotumumab is a human monoclonal antibody that blocks the IGF-1 receptor (IGF-1R). Teprotumumab binds to the extracellular α-subunit domain ligand of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab reduces TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used in the study of thyroid-associated eye diseases.
- $163
Size
QTY
Select Batch
Purity:98.35%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | TSHR antagonist S37 is a selective and competitive antagonist of the thyrotropin receptor (TSHR). |
| In vitro | cAMP activation induced by the small molecule agonist C2 reduced by TSHR antagonist S37. |
| Molecular Weight | 460.57 |
| Formula | C25H20N2O3S2 |
| Cas No. | 1217616-61-9 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 65 mg/ml (141.13 mM)  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy TSHR antagonist S37 | purchase TSHR antagonist S37 | TSHR antagonist S37 cost | order TSHR antagonist S37 | TSHR antagonist S37 chemical structure | TSHR antagonist S37 in vitro | TSHR antagonist S37 formula | TSHR antagonist S37 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.